A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01)
Patent
CA 2598273
A method of treating atherosclerosis is disclosed wherein nicotinic acid or another nicotinic acid receptor agonist is administered to the patient in combination with a DP receptor antagonist. The DP receptor antagonist is administered to reduce, prevent or eliminate flushing that may otherwise occur.
L'invention concerne une méthode de traitement de l'athérosclérose, au cours de laquelle de l'acide nicotinique ou un autre agoniste du récepteur de l'acide nicotinique est administré à un patient en combinaison avec un antagoniste du récepteur DP. Cet antagoniste du récepteur DP est administré de manière à diminuer, prévenir ou éliminer des bouffées vasomotrices qui peuvent se produire autrement.
Fitzpatrick Shaun
Hardy Ian
Lai Eseng
Seiler Christian
Waters M. Gerard
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Limited
Norton Rose Canada S.e.n.c.r.l.,s.r.l./llp
LandOfFree
Method of treating atherosclerosis, dyslipidemias and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating atherosclerosis, dyslipidemias and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating atherosclerosis, dyslipidemias and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2063574